Author Correction: PARP14 and PARP9/DTX3L regulate interferon-induced ADP-ribosylation

EMBO J. 2024 Nov;43(21):5327. doi: 10.1038/s44318-024-00247-6.

¹ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK.
² Department of Biological Sciences, SRM University-AP, Amaravati, 522502, India.
³ Univ Rennes, CNRS, IGDR (Institut de génétique et développement de Rennes) - UMR 6290, BIOSIT - UMS3480, F-35000, Rennes, France.
⁴ Research Institute of Molecular Pathology (IMP), Vienna BioCenter, Vienna, Austria.
⁵ Proteomics Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3B, 2200, Copenhagen, Denmark.
⁶ Medical University of Vienna, Vienna, Austria.
⁷ Ribon Therapeutics, Cambridge, MA, 02140, USA.
⁸ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. rebecca.smith@path.ox.ac.uk.
⁹ Sir William Dunn School of Pathology, University of Oxford, Oxford, OX1 3RE, UK. ivan.ahel@path.ox.ac.uk.

^# Contributed equally.

Abstract